This content is only available within our institutional offering.

24 Apr 2025
Hikma Pharmaceuticals (HIK LN, 2,170p, Buy) (Results Review) - 1Q trading: reassuring, perhaps even encouraging re US/tariffs

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (HIK LN, 2,170p, Buy) (Results Review) - 1Q trading: reassuring, perhaps even encouraging re US/tariffs
Hikma Pharmaceuticals Plc (HIK:LON) | 1,629 -456.1 (-1.7%) | Mkt Cap: 3,615m
- Published:
24 Apr 2025 -
Author:
Miles Dixon -
Pages:
12 -